Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma-Reference-Cited by-同舟云学术

Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma

Published:2020-04-27 Issue:5 Volume:1 Page:493-506
ISSN:2662-1347
Container-title:Nature Cancer
language:en
Short-container-title:Nat Cancer

Author:

Zavidij Oksana,Haradhvala Nicholas J.^ORCID,Mouhieddine Tarek H.^ORCID,Sklavenitis-Pistofidis Romanos,Cai Songjie^ORCID,Reidy Mairead,Rahmat Mahshid^ORCID,Flaifel Abdallah,Ferland Benjamin,Su Nang K.,Agius Michael P.^ORCID,Park Jihye,Manier Salomon,Bustoros Mark,Huynh Daisy,Capelletti Marzia,Berrios Brianna,Liu Chia-Jen^ORCID,He Meng Xiao,Braggio Esteban,Fonseca Rafael,Maruvka Yosef E.,Guerriero Jennifer L.,Goldman Melissa,Van Allen Eliezer M.^ORCID,McCarroll Steven A.,Azzi Jamil,Getz Gad^ORCID,Ghobrial Irene M.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/s43018-020-0053-3.pdf

Reference63 articles.

1. Kyle, R. A. & Rajkumar, S. V. Multiple myeloma. Blood 111, 2962–2972 (2008).

2. Landgren, O. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: biological insights and early treatment strategies. Hematology Am. Soc. Hematol. Educ. Program 2013, 478–487 (2013).

3. Rajkumar, S. V. Multiple myeloma: 2011 update on diagnosis, risk-stratification, and management. Am. J. Hematol. 86, 57–65 (2011).

4. Kyle, R. A. et al. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia 24, 1121–1127 (2010).

5. Rajkumar, S. V. et al. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood 106, 812–817 (2005).

Cited by 239 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the cellular landscape: insights from single-cell RNA sequencing in multiple myeloma;Frontiers in Immunology;2024-08-30

2. How to Identify and Manage High-Risk Smoldering Multiple Myeloma;Current Oncology Reports;2024-08-23

3. Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial;Nature Communications;2024-08-11

4. Exploring the Molecular Mechanisms and Shared Genetic Characteristics of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma;2024-08-10

5. Clinical implications of residual normal plasma cells within bone marrow across various disease stages in multiple myeloma;Leukemia;2024-08-02